Journal article icon

Journal article

Pathogen inactivation of human serum facilitates its clinical use for islet cell culture and subsequent transplantation.

Abstract:

Serum is regarded as an essential supplement to promote survival and growth of cells during culture. However, the potential risk of transmitting diseases disqualifies the use of serum for clinical cell therapy in most countries. Hence, most clinical cell therapy programs have replaced human serum with human serum albumin, which can result in inferior quality of released cell products. Photochemical treatment of different blood products utilizing Intercept® technology has been shown to inactiv...

Expand abstract

Actions


Access Document


Publisher copy:
10.3727/096368910x539056

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Surgical Sciences
Role:
Author
Journal:
Cell transplantation
Volume:
20
Issue:
5
Pages:
775-781
Publication date:
2011-01-01
DOI:
EISSN:
1555-3892
ISSN:
0963-6897
URN:
uuid:b495cc8a-37e8-4b3d-b8be-7e621e2a96cf
Source identifiers:
259001
Local pid:
pubs:259001

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP